Medicare Enrolled

Dr. Emily Hinchcliff, M.D.

Gynecologic Oncology Physician · Chicago, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
250 E SUPERIOR ST STE 4-420, Chicago, IL 60611
3126950990
Registered in NPPES since 2013
NPI: 1558707877 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hinchcliff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hinchcliff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hinchcliff

Dr. Emily Hinchcliff is a gynecologic oncology physician in Chicago, IL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Hinchcliff performed 10,151 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Hinchcliff received a total of $31,049 from 11 pharmaceutical and/or device companies across 62 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hinchcliff is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years of NPI registration ▲ Top 13% volume in IL $31,049 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
10,151
Medicare services
Top 13% in IL for gynecologic oncology physician
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Paclitaxel chemotherapy injection 5,310 $0 $2
Anti-nausea injection (fosaprepitant)
An injection of fosaprepitant, a medication used to prevent nausea and vomiting.
3,450 $0 $7
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
390 $0 $1
Anti-nausea injection (Aloxi/palonosetron) 260 $1 $76
Carboplatin chemotherapy injection, 50 mg
Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection.
200 $2 $94
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
114 $97 $323
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
90 $13 $143
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
70 $110 $940
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
44 $149 $434
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
33 $23 $215
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
31 $52 $464
New patient office visit, complex (60-74 min) 30 $172 $625
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
29 $24 $203
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
26 $1 $4
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
26 $1 $7
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
21 $68 $217
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
16 $102 $311
Laparoscopic hysterectomy with salpingo-oophorectomy, 250g or less
Surgical removal of the uterus, fallopian tubes, and/or ovaries through small abdominal incisions using a camera-guided instrument. The procedure is specified for cases where the removed tissue weighs 250 grams or less.
11 $813 $5,182
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.3% high complexity
96.1% medium
2.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$31,049
Total received (2019-2024)
Avg $6,210/year across 5 years
Top 14% in IL for gynecologic oncology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
11
Companies
62
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$29,290
2023
$238
2022
$268
2021
$445
2019
$808

Payments by company (2024)

ABBVIE INC.
$28,945
AstraZeneca Pharmaceuticals LP
$255
Merck Sharp & Dohme LLC
$65
GlaxoSmithKline, LLC.
$25
Top 3 companies account for 99.9% of 2024 payments
All-time payments by company (2019-2024) ›
ABBVIE INC.
$28,945
AstraZeneca Pharmaceuticals LP
$587
Clovis Oncology, Inc.
$413
TESARO, Inc.
$240
Stryker Corporation
$225
Foundation Medicine, Inc.
$206
Genentech USA, Inc.
$127
Merck Sharp & Dohme LLC
$124
Seattle Genetics, Inc.
$104
GlaxoSmithKline, LLC.
$53
Baxter Healthcare
$25
Top 3 companies account for 96.4% of all-time payments
Associated products mentioned in payments ›
Avastin · ELAHERE · ENHERTU · FLOSEAL · FOUNDATIONONE · JEMPERLI · KEYTRUDA · LYNPARZA · Rubraca · SPY-PHI SYSTEM · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a gynecologic oncology physician in Chicago?
Compare gynecologic oncology physicians in the Chicago area by procedure volume, costs, and industry payment transparency.
Browse gynecologic oncology physicians nearby

Geographic Context

Gynecologic oncology physicians in nearby ZIP areas
40
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
NORTHWESTERN MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hinchcliff is a mixed practice specialist, with above-average Medicare volume (top 13% in IL).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hinchcliff experienced with paclitaxel chemotherapy injection?
Based on Medicare claims data, Dr. Hinchcliff performed 5,310 paclitaxel chemotherapy injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hinchcliff receive payments from pharmaceutical companies?
Yes. Dr. Hinchcliff received a total of $31,049 from 11 companies across 62 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hinchcliff's costs compare to other gynecologic oncology physicians in Chicago?
Dr. Hinchcliff's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hinchcliff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →